Browsing by Author Baran, Yusuf


Or, select a letter below to browse by last name
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 21 to 40 of 157 < previous   next >
Issue DateTitleAuthor(s)
2010Ceramides regulate resveratrol-induced apoptosis in human acute promyelocytic and chronic myeloid leukemia cellsBaran, Yusuf ; Kartal, Melis; Çakır, Zeynep; Saydam, Güray; Şahin, Fahri
2010Changes in expression profiles of apoptosis, invasion, metastasis, angiogenesis, transcription factors, cell cycle control and tumour supressor genes in nilotinib treated chronic myeloid leukemia cellsBaran, Yusuf ; Camgöz, Aylin; Can, Geylani
2013Changes in gene expression profiles in response to apigenin in imatinib sensitive and resistant chronic myeloid leukemia cellsBaran, Yusuf ; Gökbulut, Aysun ; Cincin, Zeynep; Çakmakoğlu, Bedia; Kozanoğlu, İlknur
2013Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor eraCömert, Melda; Baran, Yusuf ; Saydam, Güray
May-2013Changes in protein profiles of multiple myeloma cells in response to bortezomibTuran, Taylan; Şanlı Mohamed, Gülşah ; Baran, Yusuf 
Jun-2010Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cellsBaran, Yusuf ; Öztekin, Coşkun; Başsoy, Esen Yonca
Sep-2014Comparative development of knowledge-based bioeconomy in the European Union and TurkeyÇelikkanat Ozan, Didem; Baran, Yusuf 
2014Comparison of ishage-based CD34 (+) cell enumeration protocols on BD facs canto ıı and attune flow cytometersKozanoğlu, İlknur; Ünver, Gülşah; Sarıtürk, Çağla; Baran, Yusuf ; Yeral, Mahmut; Boğa, Can; Özdoğu, Hakan
2012Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemiaBaran, Yusuf ; Saydam, Güray
2014Cytotoxic and apoptotic effects of fisetin, hesperetin and vitexinon acute promyelocytic leukemia cellsAdan Gökbulut, Aysun ; Baran, Yusuf 
2014Cytotoxic and cytostatic effects of ponatinib on imatinib-sensitive and-resistant chronic myeloid leukemia cellsYandım, Melis Kartal; Baran, Yusuf 
2013Cytotoxic effects of apigenin on multiple myeloma cellsBaran, Yusuf ; Yılmaz, S. ; Cincin, Zeynep; Kozanoğlu, İlknur; Çakmakoğlu, Bedia; Özdoğu, Hakan
2010Cytotoxic effects of resveratrol on imatinib sensitive and resistant K562 chronic myeloid leukemia cellsCan, Geylani; Baran, Yusuf 
2013Determination of cytotoxic and apoptotic effects of caffeic acid phenethyl ester and gossypol in combination with fludarabine at a molecular level in acute lymphoblastic leukemia cellsBaran, Yusuf ; İskender, G.; Pişkin, Özden; Özcan, Mehmet Ali
Jul-2021Determination of therapeutic effects of multifunctional antibody and peptide micelle-based nanocarriers on breast cancer cellsAbdulhadi, Nusaibah Abdulsalam Abdulhad
Jul-2019Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cellsUlu, Gizem Tuğçe 
2021Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cellsUlu, Gizem Tuğçe ; Bayram, Nazende Nur; Abdulhadi, N.; Gurdap, S.; Isoglu, A.; Isoglu, S. D.; Baran, Yusuf 
Dec-2019Determination of therapeutic potential of apigenin on acute lymphoblastic leukemia cellsUzuner, Erez
Nov-2019Determination of therapeutic potential of luteolin for acute lymphoblastic leukemia cellsGürler, Sevim Beyza
2020Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cellsGürler, Sevim Beyza; Baran, Yusuf ; Kiraz, Yağmur